Cell Biology
Cell Migration and Lamellipodia
How cells crawl — branched actin, focal adhesion turnover, and Rho-family GTPases
Cell migration is how an animal cell crawls across a surface — a repeating cycle in which the front pushes out, grips the matrix, and drags the rear along. At the leading edge, the Arp2/3 complex nucleates a dense branched-actin network that shoves the membrane forward as a flat sheet called the lamellipodium, while finger-like filopodia probe ahead. New integrin-based focal adhesions clutch the extracellular matrix and transmit traction, then actomyosin contraction hauls the trailing body up behind. The whole cycle is choreographed by three Rho-family GTPases — Rac1 at the front, Cdc42 setting direction, RhoA contracting the rear — and biased by chemical gradients (chemotaxis). It drives embryonic morphogenesis, wound healing, immune patrol, and cancer metastasis. A fibroblast crawls roughly 0.5 to 1 µm per minute; a neutrophil chasing bacteria exceeds 10 to 20 µm per minute.
- Fibroblast speed~0.5–1 µm/min
- Neutrophil speed>10–20 µm/min
- Branch angleArp2/3 ≈ 70°
- Front / direction / rearRac1 / Cdc42 / RhoA
- Gradient sensed~1–2% across cell
- GTPase mapNobes & Hall 1992–95
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why cell migration matters
- It builds the embryo. Gastrulation, neural-crest streaming, and axon-growth-cone pathfinding are all migration. Neural-crest cells delaminate from the dorsal neural tube and crawl vast distances — to the face, the gut, the adrenal medulla, and the skin — using exactly this actin-and-adhesion machinery. Errors produce neurocristopathies such as Hirschsprung disease (an aganglionic colon where enteric neural-crest cells failed to arrive).
- It closes wounds. When you cut skin, epithelial cells at the wound edge lose their apical-basal polarity, extend lamellipodia, and crawl as a sheet to re-cover the gap — a process that takes hours to days and is imaged in the ubiquitous "scratch assay." Fibroblasts and myofibroblasts migrate into the clot to lay down and contract new matrix.
- It runs the immune system. Neutrophils are the fastest human cells, chemotaxing out of blood vessels toward bacterial fMLP peptides and complement C5a at over 10 µm per minute. Dendritic cells crawl to lymph nodes; T cells scan thousands of antigen-presenting cells per hour by crawling. Leukocyte-adhesion-deficiency (defective β2 integrins) causes recurrent infections precisely because these cells cannot grip and crawl out of the bloodstream.
- It kills in cancer. Metastasis causes roughly 90% of cancer deaths, and it is migration gone rogue: carcinoma cells undergo epithelial-to-mesenchymal transition, build matrix-digesting invadopodia, and crawl into blood and lymph vessels to seed distant organs.
- It is mechanically astonishing. A crawling cell is a soft machine that converts the chemical energy of actin polymerization and myosin ATP hydrolysis into directed motion with no wheels, no rigid skeleton, and no external anchor beyond a sticky floor — moving its own body weight forward against fluid drag and adhesion, and reversing on command when the gradient flips.
- It is a drug target. Anti-migratory and anti-invasive strategies — ROCK inhibitors, Rac inhibitors like EHT 1864, and MMP inhibitors — are being pursued to block metastasis and fibrosis, though the machinery's overlap with normal wound healing and immunity makes clean targeting hard.
How cell migration works, step by step
Mesenchymal crawling on a two-dimensional substrate runs as a four-phase cycle that repeats indefinitely: protrude, adhere, translocate, retract. The steps overlap in space along the front-to-back axis, so a moving cell is doing all four simultaneously in different regions.
1. Protrusion. At the leading edge, the small GTPase Rac1 (loaded with GTP by GEFs such as Tiam1 and DOCK180) together with the membrane lipid PIP2 activates the WAVE regulatory complex. WAVE presents an actin monomer and the flank of a "mother" filament to the Arp2/3 complex, a seven-subunit machine whose Arp2 and Arp3 subunits mimic an actin dimer. Arp2/3 nucleates a new "daughter" filament that branches off at a characteristic 70-degree angle. Because each daughter can be re-branched, the result is an exponentially expanding dendritic meshwork whose barbed (growing) ends all face the membrane. Capping protein terminates most filaments after ~100–200 nm, keeping them short and stiff; profilin-charged G-actin feeds the growing ends. The collective polymerization pushes the membrane outward by a Brownian-ratchet mechanism — thermal fluctuations of the membrane open a gap, a subunit inserts, and the filament ratchets the edge forward. In parallel, Cdc42 drives finger-like filopodia: parallel bundles of 10–30 unbranched filaments, cross-linked by fascin and elongated at their tips by formins (mDia2) and Ena/VASP proteins, that act as antennae probing the terrain.
2. Adhesion. Under the fresh protrusion, transmembrane integrins engage the extracellular matrix (fibronectin, collagen, laminin) and cluster into nascent adhesions. Adaptor proteins — talin, vinculin, paxillin, and the enzyme focal adhesion kinase (FAK) — assemble on the integrin tails and physically link them to the actin network. Talin acts as a mechanosensitive clutch: when actin retrograde flow pulls on it, talin unfolds and exposes cryptic vinculin-binding sites, reinforcing the adhesion under load.
3. Translocation. With the front anchored, the cell body and nucleus move forward. Actin filaments in the lamellipodium constantly flow rearward ("retrograde flow"); when the clutch engages the substrate, that flow is converted into forward traction rather than being wasted, and the whole cell is pulled up over its adhesions.
4. Retraction. At the rear, RhoA activates ROCK and the formin mDia1. ROCK phosphorylates myosin light chain (and inhibits its phosphatase), switching on myosin II. Bipolar myosin II filaments slide antiparallel actin filaments, contracting the network and generating the tension that hauls the trailing edge forward. Rear focal adhesions disassemble — microtubules target them for turnover, and the protease calpain cleaves talin and FAK to release the grip — so the tail detaches and snaps up. The cycle then repeats.
Directionality comes from chemotaxis. G-protein-coupled receptors read a soluble gradient; even a 1–2% concentration difference across a 10-µm cell is amplified internally into a steep compass by PI3-kinase making PIP3 at the front and the phosphatase PTEN clearing it at the sides and rear. This biases Rac1/Cdc42 activation — and therefore protrusion — toward the source (the local-excitation, global-inhibition model).
Lamellipodia vs filopodia vs invadopodia
| Feature | Lamellipodium | Filopodium | Invadopodium |
|---|---|---|---|
| Shape | Broad flat sheet | Thin finger / spike | Ventral punctate protrusion |
| Actin architecture | Dendritic branched (Arp2/3) | Parallel bundle (fascin) | Branched + bundled core |
| Main GTPase | Rac1 | Cdc42 | Cdc42 / RhoC |
| Key elongators | Arp2/3, capping protein | Formin mDia2, Ena/VASP | N-WASP, cortactin, Tks5 |
| Primary job | Generate protrusive force | Sense & steer | Digest the matrix (MT1-MMP) |
| Typical dimensions | 1–5 µm deep, ~0.2 µm thick | 0.1–0.3 µm wide, µm-long | ~0.5 µm wide, µm-deep |
| Where it matters | General crawling, wound sheets | Growth cones, endothelial tips | Cancer invasion, metastasis |
Mesenchymal vs amoeboid migration
| Property | Mesenchymal | Amoeboid |
|---|---|---|
| Cell shape | Elongated, spread, front-rear polarized | Rounded, blebbing or gliding |
| Adhesion | Strong, integrin focal adhesions | Weak, transient or adhesion-independent |
| Leading structure | Arp2/3 lamellipodium | Membrane blebs, cortical flow |
| Contractility | Moderate (stress fibers) | High (RhoA/ROCK cortex) |
| Matrix degradation | Yes — MMP/invadopodia proteolysis | No — squeezes through pores |
| Speed | Slow (~0.1–1 µm/min) | Fast (up to ~20 µm/min) |
| Examples | Fibroblasts, epithelial sheets | Leukocytes, some carcinoma cells |
Many tumor cells switch between the two modes ("mesenchymal-amoeboid transition") when one is blocked, which is why single-pathway anti-invasion drugs so often fail — inhibit the proteases and the cell simply rounds up and squeezes through instead.
Common misconceptions
- "The lamellipodium pulls the cell forward." It pushes the membrane outward by actin polymerization; the force is a compression against the membrane, not a pull. The forward pull on the cell body comes later, from myosin-II contraction at the rear and from traction where adhesions convert retrograde actin flow into substrate grip.
- "Faster actin polymerization means faster cells." Not usually. Barbed ends can elongate fast enough to move a cell far quicker than it actually goes; the rate-limiting step is coordinating adhesion turnover and rear retraction. Migration speed is biphasic with adhesion strength — too weak and there is no traction, too strong and the rear cannot release — so a cell peaks at an intermediate stickiness.
- "Cdc42 builds the lamellipodium." Cdc42 builds filopodia and sets overall direction/polarity. Rac1 builds the branched-actin lamellipodium via WAVE and Arp2/3. Confusing the two reverses the classic Nobes–Hall assignments.
- "Focal adhesions are static anchors." They are dynamic clutches in constant turnover. Nascent adhesions form under the protrusion and either disassemble within ~60 seconds or mature under tension; rear adhesions are actively dismantled by microtubules and calpain. A cell that could not disassemble adhesions would be glued in place.
- "Chemotaxis means the cell physically feels the gradient direction." The external gradient is often shallower than 2% across the cell — far too weak to read directly. The cell amplifies that tiny asymmetry internally through PIP3/PTEN signaling into a sharp intracellular polarity, essentially manufacturing a steep compass from a nearly flat cue.
- "All cells crawl the same way." Mesenchymal crawling on a dish is only one mode. In 3D tissue, leukocytes and some cancer cells use adhesion-independent amoeboid migration, and cells can migrate collectively as connected sheets or chains — with leader cells at the front and followers behind — rather than as lone crawlers.
Famous experiments and history
- Abercrombie's ruffling membrane (1960s–70s). Michael Abercrombie used interference-reflection microscopy on fibroblasts to describe the "ruffling membrane" at the leading edge and the phenomenon of contact inhibition of locomotion — cells stop and turn away when they touch a neighbor. His work established the front-to-back cycle of protrusion, attachment, and rear retraction that still frames the field.
- Nobes & Hall microinjection (1992–1995). Catherine Nobes and Alan Hall microinjected constitutively active Rho, Rac, and Cdc42 into fibroblasts and read out the cytoskeleton: activated Rac produced lamellipodia and ruffles, Cdc42 produced filopodia, and Rho produced stress fibers and focal adhesions. This defined the three-GTPase division of labor that underpins all modern models of migration.
- The fish keratocyte model. Epithelial keratocytes from fish skin crawl fast (5–10 µm/min) with a strikingly stable, fan-shaped lamellipodium that barely changes shape. Their steadiness made them the ideal system for measuring actin retrograde flow, the graded-radial-extension model of movement, and traction forces — Julie Theriot and colleagues used them to show the lamellipodial actin array treadmills as a coherent whole.
- Reconstitution of actin-based motility (1999). Marie-France Carlier, Thomas Pollard, and others reconstituted actin-comet-tail motility of the bacterium Listeria monocytogenes — and then of coated beads — from purified proteins (actin, Arp2/3, capping protein, ADF/cofilin, profilin, and a nucleation-promoting factor). This minimal system proved that Arp2/3-based branched-actin polymerization alone can generate propulsive force, the same engine that runs the lamellipodium.
- Traction-force microscopy. By plating cells on deformable elastic gels embedded with fluorescent beads and tracking bead displacement, researchers (Micah Dembo, Yu-li Wang, and others) mapped the piconewton-to-nanonewton traction stresses a crawling cell exerts — showing the strongest pull concentrates just behind the leading edge and at the retracting rear, exactly where the clutch engages and myosin contracts.
Frequently asked questions
What is the difference between a lamellipodium and a filopodium?
Both are actin-based protrusions at the leading edge, but their architecture and geometry differ. A lamellipodium is a broad, flat sheet — typically 1 to 5 micrometers deep and only about 0.1 to 0.2 micrometers thick — filled with a dense, dendritically branched actin meshwork. The Arp2/3 complex nucleates new filaments at a 70-degree angle off the sides of existing ones, and the whole network pushes the membrane forward like a broad plow. A filopodium is a thin, finger-like spike, roughly 0.1 to 0.3 micrometers wide and up to several micrometers long, built from a tight parallel bundle of 10 to 30 unbranched actin filaments cross-linked by fascin and elongated at the tip by formins (mDia2) and Ena/VASP proteins. Functionally, Rac1 drives lamellipodia while Cdc42 drives filopodia; filopodia act as antennae that probe the environment and steer the cell, while the lamellipodium provides the main protrusive force.
How does the Arp2/3 complex build the lamellipodium?
Arp2/3 is a seven-subunit protein complex containing two actin-related proteins (Arp2 and Arp3) that mimic an actin dimer. On its own it is nearly inactive; it must be switched on by nucleation-promoting factors of the WASP/WAVE family. At the lamellipodium, Rac1-GTP and the phospholipid PIP2 activate the WAVE regulatory complex, which delivers an actin monomer and the side of an existing 'mother' filament to Arp2/3. The complex then nucleates a new 'daughter' filament that branches off at a characteristic 70-degree angle. Because each new filament can itself be branched, this produces an exponentially expanding dendritic array whose barbed (fast-growing) ends all point toward the membrane. Capping protein terminates most filaments after roughly 100 to 200 nanometers, keeping them short and stiff so that their collective polymerization generates protrusive force through a Brownian-ratchet mechanism rather than long floppy filaments that would buckle.
What do Rho, Rac, and Cdc42 GTPases do in cell migration?
These three Rho-family small GTPases are the master molecular switches of migration, cycling between an active GTP-bound state (loaded by GEFs) and an inactive GDP-bound state (switched off by GAPs). Rac1 activates the WAVE complex and Arp2/3 to build the branched-actin lamellipodium at the front. Cdc42 sets front-rear polarity and drives filopodia through WASP and formins, and it orients the cell toward a chemotactic cue. RhoA activates the kinase ROCK and the formin mDia1, driving myosin II contractility, stress-fiber assembly, and mature focal adhesions — mainly at the cell body and rear, where contraction retracts the tail. Catherine Nobes and Alan Hall's microinjection experiments in the early 1990s established this division of labor: injecting activated Rac produced ruffling lamellipodia, Cdc42 produced filopodia, and Rho produced stress fibers and focal adhesions. The three activities are spatially segregated and mutually antagonistic, which is how a cell keeps a distinct front and back.
What is focal adhesion turnover and why does it matter?
Focal adhesions are integrin-based clutches that physically link the actin cytoskeleton to the extracellular matrix through proteins like talin, vinculin, paxillin, and focal adhesion kinase (FAK). For a cell to move, adhesions must form dynamically under the new protrusion and then disassemble under the retracting rear — a treadmill of assembly and disassembly called turnover. Small nascent adhesions form in the lamellipodium and either turn over within about 60 seconds or mature under tension into larger focal adhesions. If adhesions are too weak, the cell cannot grip and generate traction; if too strong, the rear cannot release and the cell stalls — migration speed peaks at an intermediate adhesion strength, a biphasic relationship first quantified by Douglas Lauffenburger and colleagues in 1997. Calpain protease cleaves talin and FAK to help release rear adhesions, and FAK-null cells migrate poorly because their adhesions fail to turn over.
How does a cell sense which direction to move (chemotaxis)?
Chemotaxis is directed migration up (or down) a gradient of a soluble chemical cue. A neutrophil or a Dictyostelium amoeba can detect a concentration difference of only about 1 to 2 percent across its ~10-micrometer length — a handful of extra receptor-occupancy events on the front versus the back. Chemoattractants such as the bacterial peptide fMLP, the chemokine CXCL8/IL-8, or cyclic-AMP in Dictyostelium bind G-protein-coupled receptors that are distributed uniformly over the surface, yet the internal signaling response is sharply amplified and polarized. PI3-kinase generates the lipid PIP3 at the front while the phosphatase PTEN clears it at the sides and rear, creating a steep internal compass. This biases Rac1/Cdc42 activation and Arp2/3-driven protrusion toward the source, so the cell steers even in a very shallow external gradient — a signal-amplification phenomenon known as directional sensing or the local-excitation, global-inhibition (LEGI) model.
How does cell migration drive cancer metastasis?
Metastasis — the spread of cancer to distant organs — is responsible for roughly 90 percent of cancer deaths, and it hijacks the normal migration machinery. Carcinoma cells undergo an epithelial-to-mesenchymal transition (EMT), losing E-cadherin junctions and gaining a motile, front-rear-polarized phenotype driven by the same Rac/Rho/Arp2/3 program. To cross the basement membrane, invasive cells build specialized actin-rich protrusions called invadopodia that concentrate matrix metalloproteinases (MT1-MMP, MMP-2, MMP-9) to digest the matrix. Cells then intravasate into blood or lymphatic vessels, survive in circulation, extravasate at a distant site, and colonize it. Tumor cells can switch between mesenchymal crawling (adhesion-dependent, elongated) and amoeboid squeezing (RhoA/ROCK-driven, low-adhesion, protease-independent), a plasticity that makes single-target anti-migration therapy difficult. Because the leading-edge machinery is shared with normal wound healing and immune surveillance, blocking it cleanly without toxicity is a central challenge in oncology.
How fast do cells actually crawl?
Speed varies enormously by cell type. A tissue fibroblast is slow, crawling roughly 0.5 to 1 micrometer per minute — a few cell-lengths per hour. Epithelial keratocytes from fish skin are among the fastest sustained crawlers, gliding at 5 to 10 micrometers per minute with a strikingly steady fan-shaped lamellipodium that made them a classic model system. Immune cells are faster still: a human neutrophil chasing a bacterium can exceed 10 to 20 micrometers per minute, and activated T cells scanning lymph nodes move at similar speeds. The rate-limiting step is not usually actin polymerization — barbed ends can add subunits fast enough to move much quicker — but the coordination of adhesion turnover and rear retraction. This is why the same cell speeds up or slows down dramatically depending on how sticky its substrate is, following the biphasic adhesion-speed curve.